Nureca Limited — Others, 24-02-2025: Shareholders meeting

NURECA has announced a board meeting to conduct a postal ballot for shareholder approval on the appointment of Dr. Rupinder Tewari and Dr. Kuldip Kumar Bhasin as Independent Directors, along with the continuation of Dr. Bhasin’s tenure. The voting period starts on March 1, 2025, and ends on March 30, 2025, with results to be declared by April 1, 2025. This move is aimed at enhancing the board's expertise in healthcare, critical for Nureca’s growth in the home healthcare sector, likely favoring investor sentiment due to strengthened governance and leadership continuity.